z-logo
open-access-imgOpen Access
Efficacy and safety of methylprednisolone pulse followed by oral prednisone vs. oral prednisone alone in sarcoidosis tubulointerstitial nephritis: a randomized, open-label, controlled clinical trial
Author(s) -
Matthieu Mahévas,
Vincent Audard,
Alexandra Rousseau,
Alexandre Cez,
Dominique Guerrot,
David Verhelst,
Michel Delahousse,
Catherine Hanrotel,
Évangéline Pillebout,
Éric Daugas,
Evguenia Krastinova,
Dominique Valeyre,
JeanJacques Boffa,
Papo Thomas,
Cottin Vincent,
Lionet Arnaud,
Dominique Chauveau,
Naccache Jean-Marc,
Sandrine Hirschi,
Choukroun Gabriel,
Simon Tabassome,
Admane Hakeem,
Berard Laurence,
Hummel Aurélie,
Vrigneaud Laurence,
Godeau Bertrand,
J. Laurent,
Dussol Bertrand,
Bruno Moulin
Publication year - 2022
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfac227
Subject(s) - medicine , prednisone , interquartile range , methylprednisolone , renal function , gastroenterology , randomization , population , clinical endpoint , randomized controlled trial , kidney disease , urology , environmental health

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom